Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Antimicrobial stewardship

Sort by: Newest first Oldest first A-Z Z-A

  • Pills (Klenova/Dreamstime.com)

    Why are there so few antibiotics in the research and development pipeline? Subscription

    Elizabeth Sukkar finds out that there are a number of incentives to aid the development of new antibiotics. But will society be prepared to pay the price?

  • Which antibiotics and vaccines should be used for meningococcal disease? Subscription

    A local GP has telephoned to arrange for a four-year-old boy to be admitted to the paediatric ward with suspected meningitis. The child has had a fever, loss of appetite and nausea since yesterday but in the past four hours his condition has deteriorated.

  • Urinary tract infection (UTI) is one of the most common reasons for using antibiotics in both primary and secondary care. Escherichia coli (micrograph pictured) is still the most common causative organism

    Urinary tract infection: management in elderly patients Subscription

    Around 10% of older people, and almost a third of care home residents, develop a urinary tract infection each year.

  • Understanding antibiotic resistance Subscription

    Antibiotic resistance can be described as microbiological or clinical. Microbiological resistance exists when an organism possesses any resistance mechanism (see Panel 1 for examples). Clinical resistance can be explained as failure to achieve a concentration of antimicrobial that inhibits the growth of the organism in a particular tissue or fluid.

  • Chlamydia (pictured) is one of a series of sexually transmitted infections (STIs) that have increased considerably in the last ten years

    Treating bacterial sexually transmitted infections Subscription

    With azithromycin made available over the counter for chlamydia treatment, this CPD article reviews how to identify and treat the most prevalent sexually transmitted infections.

  • Time to review short courses of antibiotics Subscription

    Edward C. F. Wilson, MSc, is lecturer in health economics, Health Economics Group, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich.John V. Wilson, MRPharmS, FRSPH, is pharmacist (retired) and former regional prescribing adviser, NHS Executive, Trent.

  • The right drug for the right bug Subscription

    By Hayley Wickens and Paul Wade

  • Illustration of MRSA cells

    The global race to combat antimicrobial resistance Subscription

    The Longitude Prize has relaunched after 300 years and this time teams around the world are racing to develop a rapid point-of-care diagnostic test that will help prevent the overuse of antibiotics and put them in the running to win £8m.

  • New drugs are under development to reduce the use of antibiotics in animals and help slow the rise of antimicrobial resistance in humans

    Strategies to reduce the use of antibiotics in animals Subscription

    New drugs that could eventually replace or reduce the use of antibiotics in animals are in development to help slow the rise of antibiotic resistance.

  • Spotlight on medicines: Doripenem Subscription

    While media attention focuses on battling MRSA and C diff, some strains of Gram-negative bacteria have developed resistance to many antibiotics. A new carbapenem is a useful addition to the arsenal

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.